Companies: 10,795·Total market cap: $144.5T

BELLUS Health Inc.

BELLUS Health Inc.

BLUNASDAQHealthcare

$14.75

+$0.01(+0.03%)

Market Cap$1.9B

P/E Ratio—

52W High$14.76

52W Low$6.38

Avg Volume2.9M

Open$14.74

Beta-0.28

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

BELLUS Health Inc.（BLU）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · BLU · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-0.52Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$3.2BFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding115.4MShares outstanding history

Next EarningsTBAEarnings history

探索 BELLUS Health Inc. 数据

分析师预测$15 · Hold

股息不分红

营收$16000+0.00%

盈利EPS $-0.66+26.67%

财务快照

FY 2022Revenue$16000.00▲ +0.00% YoY

202020212022

FY 2022Net Income-$76.1M▼ 6.82% YoY

202020212022

FY 2022EPS$-0.66▲ +26.67% YoY

202020212022

TTM:Revenue: $3.17BNet Income: -$108.2MEPS: $-0.52View income statement →

分析师评级与目标价

Hold6 位分析师

Strong Buy

0

Buy

2

Hold

4

Sell

0

Strong Sell

0

12-Month Price Target

$14.75Low

$14.74Current

$14.75Avg Target上涨空间 0.03%

$14.75High

合计: 6 · 买入占比: 33.3%

根据过去 3 个月内 6 位华尔街分析师，BLU 共识评级为 Hold，12 个月平均目标价 $14.75 （较现价 $14.74 上涨空间 0.03%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

BELLUS Health Inc.

$14.75+0.03%$1.9B #2

Ambrx Biopharma Inc.

$28.00+0.07%$1.8B #3

Astrana Health, Inc.

$38.39+1.05%$1.9B #4

Calliditas Therapeutics AB (publ)

$40.00-0.10%$1.1B #5

CinCor Pharma, Inc.

$29.06+0.00%$1.3B #6

CTI BioPharma Corp.

$9.10+0.06%$1.2B

股票表现

1D+0.00%

1W+0.00%

1M+0.03%

3M+1.76%

YTD+73.06%

1Y+50.77%

5Y+872.47%

关于 BELLUS Health Inc.

CEORoberto Francesco Bellini

IPO DateOct 27, 2000

Employees74

CountryCA

Websitebellushealth.com

BELLUS Health Inc. is a clinical-stage biopharmaceutical company headquartered in Laval, Canada, and founded in 1993. The firm focuses on developing therapeutic solutions for refractory chronic cough …

Biotechnology HealthcareNASDAQCA

关于股票概览与关键数据

BELLUS Health Inc.（BLU）是 Biotechnology 行业的 Healthcare 类公司，于 Oct 27, 2000 在 NASDAQ 上市。截至最近交易日，BLU 股价为 $14.74，市值约为 $1.9B。过去12个月累计回报 +50.77%，年初至今回报 +73.06%。

根据 6 位华尔街分析师，BELLUS Health Inc. 股票共识评级为Hold，12个月平均目标价为 $14.75。2022 财年 BELLUS Health Inc. 营收 $16000.00，净利润 -$76.1M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，BELLUS Health Inc.（BLU）股价为 $14.74，在 NASDAQ 上市，52周区间为 $6.38 – $14.76。

BLU 最新股价BLU quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议